Search publications

Publications

  • San L, Arranz B, Pérez V, Sánchez B, Dolz M, Pardo M and Álvarez E.

    FIRST-EPISODE PSYCHOSIS: GENDER DIFFERENCES IN SUBSTANCE USE

    SCHIZOPHRENIA RESEARCH . 117(2-3, SI): 424-425.

    [doi:10.1016/j.schres.2010.02.781]

  • Ramirez N, Arranz B, Salavert J, Alvarez E, Corripio I, Dueñas RM, Perez V and San L.

    Predictors of schizophrenia in patients with a first episode of psychosis

    PSYCHIATRY RESEARCH . 175(1-2): 11-14. Number of citations: 11

    [doi:10.1016/j.psychres.2009.03.013]

  • San L and Arranz B.

    Agomelatina: un nuevo enfoque antidepresivo para una remisión de calidad

    REVISTA DE PSIQUIATRIA Y SALUD MENTAL . 3(1): 15-20.

  • Arranz B, Brebion G, Haro JM, Ochoa S, Ramos B, San L, Stephan-Otto C, Usall J and Villalta-Gil V.

    The Saint John of God Mental Health Research Group in Barcelona

    EUROPEAN JOURNAL OF PSYCHIATRY . 23: 70-75.

  • Arranz B, San L, Ramírez N, Dueñas RM, Perez V, Salavert J, Corripio I and Alvarez E.

    Clinical and serotonergic predictors of non-affective acute remitting psychosis in patients with a first-episode psychosis

    ACTA PSYCHIATRICA SCANDINAVICA . 119(1): 71-77. Number of citations: 12

    [doi:10.1111/j.1600-0447.2008.01253.x]

  • San L and Arranz B.

    Agomelatine: A novel mechanism of antidepressant action involving the melatonergic and the serotonergic system

    EUROPEAN PSYCHIATRY . 23(6): 396-402. Number of citations: 84

    [doi:10.1016/j.eurpsy.2008.04.002]

  • Karagianis J, Hoffmann VP, Arranz B, Treuer T, Maguire GA, de Haan L and Chawla B.

    Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain

    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL . 23(4): 275-281. Number of citations: 11

    [doi:10.1002/hup.933]

  • Arranz B, Rosel P, San L, Ramírez N, Dueñas RM, Salavert J, Centeno M and del Moral E.

    Low baseline serotonin-2A receptors predict clinical response to olanzapine in first-episode schizophrenia patients

    PSYCHIATRY RESEARCH . 153(2): 103-109. Number of citations: 11

    [doi:10.1016/j.psychres.2006.12.015]

  • Arranz B and San L.

    What do we know about insulin resistance and glucose metabolism in patients with schizophrenia treated with antipsychotics?

    JOURNAL OF CLINICAL PSYCHIATRY . 68(5): 800-801.

    [doi:10.4088/JCP.v68n0522d]

  • San L and Arranz B.

    The functioning of the Behavioral Activation and Inhibition Systems in bipolar I euthymic patients and its influence in subsequent episodes over an eighteen-month period

    PERS INDIV DIFFER . 42(7): 1323-1331. Number of citations: 52

    [doi:10.1016/j.paid.2006.10.010]